|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Role of endoscopic ultrasound during hospitalization for acute pancreatitis显示文摘Endoscopic ultrasound(EUS)is often used to detect the cause of acute pancreatitis(AP)after the acute attack has subsided.The limited data on its role during hospitalization for AP are reviewed here.The ability of EUS to visualize the pancreas and bile duct,the sonographic appearance of the pancreas,correlation of such appearance to clinical outcomes and the impact on AP management are analyzed from studies.The most important indication for EUS appears to be for detection of suspected common bile duct and/or gall bladder stones and microlithiasis.Such an approach might avoid diagnostic endoscopic retrograde cholangio-pancreatography with its known complications.The use of EUS during hospitalization for AP still appears to be infrequent but may become more frequent in future. | Vikram Kotwal Rupjyoti Talukdar Michael Levy Santhi Swaroop Vege | 2010 | World Journal of Gastroenterology2010,16,39: | 6 |
| 2 | Peripancreatic collections in acute pancreatitis: Correlation between computerized tomography and operative fi ndings显示文摘AIM: To evaluate the ability of contrast-enhanced computerized tomography (CECT) to characterize the nature of peripancreatic collections.METHODS: Twenty five patients with peripancreatic collections on CECT and who underwent operative intervention for severe acute pancreatitis were retrospectively studied. The collections were classified into (1) necrosis without frank pus; (2) necrosis with pus; and (3) fluid without necrosis. A blinded radiologist assessed the preoperative CTs of each patient for necrosis and peripancreatic fluid collections. Peripancreatic collections were described in terms of volume, location, number, heterogeneity, fluid attenuation, wall perceptibility, wall enhancement, presence of extraluminal gas, and vascular compromise.RESULTS: Fifty-four collections were identif ied at operation, of which 45 (83%) were identif ied on CECT. Of these, 25/26 (96%) had necrosis without pus, 16/19 (84%) had necrosis with pus, and 4/9 (44%) had fluid without necrosis. Among the study characteristics, fluid heterogeneity was seen in a greater proportion of collections in the group with necrosis and pus, compared to the other two groups (94% vs 48% and 25%, P = 0.002 and 0.003, respectively). Among the wall characteristics, irregularity was seen in a greater proportion of collections in the groups with necrosis with and without pus, when compared to the group with fluid without necrosis (88% and 71% vs 25%, P = 0.06 and P < 0.01, respectively). The combination of heterogeneity and presence of extraluminal gas had a specif icity and positive likelihood ratio of 92% and 5.9, respectively, in detecting pus. CONCLUSION: Most of the peripancreatic collections seen on CECT in patients with severe acute pancreatitis who require operative intervention contain necrotic tissue. CECT has a somewhat limited role in differentiating the different types of collections. | Santhi Swaroop Vege Joel G Fletcher Rupjyoti Talukdar Michael G Sarr | 2010 | World Journal of Gastroenterology2010,16,34: | 5 |
| 3 | The New Revised Classification of Acute Pancreatitis 2012显示文摘 | Michael G. Sarr Peter A. Banks Thomas L. Bollen Christos Dervenis Hein G. Gooszen Colin D. Johnson Gregory G. Tsiotos Santhi Swaroop Vege | 2013 | Surgical Clinics of North America2013,,3: | 3 |
| 4 | Differences in Clinical Profile and Relapse Rate of Type 1 Versus Type 2 Autoimmune Pancreatitis显示文摘 | Raghuwansh P. Sah Suresh T. Chari Rahul Pannala Aravind Sugumar Jonathan E. Clain Michael J. Levy Randall K. Pearson Thomas C. Smyrk Bret T. Petersen Mark D. Topazian Naoki Takahashi Michael B. Farnell Santhi S. Vege | 2010 | Gastroenterology2010,,1: | 3 |
| 5 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘 | Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari | 2013 | Gut2013,,11: | 2 |
| 6 | Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience显示文摘 | Phil A Hart Mark D Topazian Thomas E Witzig Jonathan E Clain Ferga C Gleeson Robin R Klebig Michael J Levy Randall K Pearson Bret T Petersen Thomas C Smyrk Aravind Sugumar Naoki Takahashi Santhi S Vege Suresh T Chari | 2013 | Gut2013,,11: | 2 |
| 7 | Disconnected pancreatic duct syndrome in severe acute pancreatitis: clinical and imaging characteristics and outcomes in a cohort of 31 cases显示文摘 | Mario Pelaez-Luna Santhi Swaroop Vege Bret T. Petersen Suresh T. Chari Jonathan E. Clain Michael J. Levy Randal K. Pearson Mark D. Topazian Michael B. Farnell Michael L. Kendrick Todd H. Baron | 2008 | Gastrointestinal Endoscopy2008,,1: | 2 |
| 8 | Recent developments in acute pancre- atitis 显示文摘 | Talukdar R Vege SS | 2009 | Clin Gastroenterol Hepatol2009,7,11: | 1 |
| 9 | 23Na TQF NMR imaging for the study of spinal disc tissue显示文摘 | Ooms KJ Cannella M Vege AJ | 2008 | J Magn Reson2008,195,1: | 1 |
| 10 | Endoacopic retrograde cholangiopancreatography-induced severe acute pancreatitis 显示文摘 | Vege SS Chari ST Petersen BT | 2006 | Pancreatology2006,6,6: | 1 |
| 11 | Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience显示文摘 | Suresh T. Chari Thomas C. Smyrk Michael J. Levy Mark D. Topazian Naoki Takahashi Lizhi Zhang Jonathan E. Clain Randall K. Pearson Bret T. Petersen Santhi Swaroop Vege Michael B. Farnell | 2006 | Clinical Gastroenterology and Hepatology2006,,8: | 1 |
| 12 | Surfactantprotein A and D gene polymorphisms and protein expressionin victims of sudden infant death显示文摘 | Stray-Pedersen A Vege A Opdal S H | 2009 | Acta Paediatr2009,98,1: | 1 |
| 13 | Low mortality and high morbidity in severe acute pancreatitis without organ failure:a case for revising the Atlanta classification to include 'moderately severe acute pancreatitis' 显示文摘 | Vege SS Gardner TB Chari ST | 2009 | Am J Gastroentero12009,104,3: | 1 |
| 14 | Low mortality and high morbidity in severe acute pancreatitis without organ failure:a case for revising the Atlanta classification to include 'moderately severe acute pancreatitis'显示文摘 | Vege SS Gardner TB Chari ST | 2009 | Am J Gastroenterol2009,104,3: | 1 |
| 15 | Low mortality and highmorbidity in severe acute pancreatitis without organ failure:a casefor revising the Atlanta classification to include“moderately severeacute pancreatitis”显示文摘 | Vege SS Gardner TB Chari ST | 2009 | Am J Gastroenterol2009,104,3: | 1 |
| 16 | Epidemiology of pancreatic cancer显示文摘 | SUGUMAR A VEGE S S | 2013 | Epidemiol Dis Clin Methodol2013,28,: | 1 |
| 17 | Early management of severe acute pancreatitis显示文摘 | Talukdar R Swaroop Vege S | 2011 | Curr Gastroenterol Rep2011,13,: | 1 |
| 18 | Modern treatment of patients with chronic pancreatitis 显示文摘 | TRIKUDANATHAN G NAVANEETHAN U VEGE S S | 2012 | Gastroenterol Clin North Am2012,41,1: | 1 |
| 19 | Functional gastrointestinal disorders among people with sleep disturbances: a population-based study 显示文摘 | Vege SS Loeke GR Weaver AL | 2004 | Mayo ClinProc2004,79,12: | 1 |
| 20 | Early management of severe acute pancreatitis 显示文摘 | Talukdar R Swaroop Vege S | 2011 | Curr Gastroenterol Rep2011,13,2: | 1 |